Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-20-124504

Director sold 8,000 shares at $8.00 ($64,000)

  • Director acquired 8,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2020-11-10 Option exercise +8,000 $3.45 $27,600 133,046 D
Kraus Al Director 2020-11-10 Sale −8,000 $8.00 $64,000 125,046 D
Derivatives
Kraus Al Director 2020-11-10 Option exercise · Stock Option (right to buy) −8,000 0 D
Open-market sales · 8,000 sh · avg $8.00 · $64,000
Loading xslF345X03/tm2035834-1_4.xml…